phrykt

Nelson Peltz portfolio: Trian Fund Management holdings

As of Sep 30, 2026, Trian Fund Management reported 8 US stock holdings worth $2.6B in its 13F filed Nov 16, 2026. Its largest holding was Ge Aerospace at 48.5% of the reported portfolio. Compared with Q2 2026, it opened 2 new positions, added shares in 0, reduced 1 and closed 2.

Nelson Peltz: Co-founder and CEO. Updated Nov 17, 2026; next 13F due Feb 16, 2027.

Reported value, Q3 2026$2.6BDown 39% since Q2 2026. Prices and trades both move it.
Top 10 holdings100% of the portfolio
8 stocks in all.
Latest 13FQ3 2026 filed Nov 16This is the newest quarter.

What changed in Q3 2026

All holdings

Against Q2 2026, ranked by how much each move changed the portfolio. A 13F shows the position at the quarter end, not the day of the trade.

New positions1
  • RTO0.5% of portfolio
Added to0
  • Nothing this quarter
Trimmed1
  • IVZ−83% shares · 1.0% → 0.3%
Sold out1
  • Janus Hendersonwas 31.5%

Top 8 holdings

How long each position has been held, what it probably cost, and how many of the other investors we track hold it too.

StockOf portfolioHeld sinceEst. price paidPrice, Sep 30Since boughtAlso held by
GEGe Aerospace48.5%Q3 2023 or earlier13 quarters in a row+before our data$312.29–9 of 49
SOLVSolventum Corporation28.0%Q2 202410 quarters in a row$58.48$88.15+51%8 of 49
GEHCGe Healthcare Technologies7.8%Q3 2023 or earlier13 quarters in a row+before our data$65.37–8 of 49
WENWendys7.5%Q3 2023 or earlier13 quarters in a row+before our data$6.38–6 of 49
FERGFerguson Enterprises7.3%First reported Q3 2026new to the 13Fthis quarter$222.62–7 of 49
RTORentokil Initial0.5%First reported Q3 2026new to the 13Fthis quarter$19.75–3 of 49
IVZInvesco0.3%Q3 2023 or earlier13 quarters in a row+before our data$30.16–4 of 49
MICCMagnum Ice Cream Co Nv0.2%Q1 20263 quarters in a row$14.95$17.78+19%4 of 49

The price paid is an estimate: shares added in a quarter are counted at that quarter's closing price, because a 13F does not give the trade date or price. Both prices come from the filings themselves, so "since bought" runs to the end of Q3 2026, not to today.

Portfolio map

Box size is the share of the portfolio. Green boxes were added to, red ones were trimmed.

Ge Aerospace: 48.5% of the portfolio, shares 0.0%GE48.5% 0.0%Solventum Corporation: 28.0% of the portfolio, shares 0.0%SOLV28.0% 0.0%Ge Healthcare Technologies Inc.: 7.8% of the portfolio, shares 0.0%GEHC7.8% 0.0%Wendys Co.: 7.5% of the portfolio, shares 0.0%WEN7.5% 0.0%Ferguson Enterprises Inc.: 7.3% of the portfolio, shares new positionFERG7.3% new

Box size: share of the portfolio. First number: weight. Second: change in shares since Q2 2026. Bought more Sold some No change in shares · 5 largest positions, 99% of the portfolio.

Largest trades in Q3 2026

Ordered by the value of the shares bought or sold, at the quarter-end price. The bars show the shares held in each of the last 5 quarters.

Largest buys in Q3 2026

StockOf portfolioLatest activitySharesValueLast 5 quarters
FERGFerguson Enterprises Inc.7.3%NEW (+$190M)855,015$190MQ3 2025: none, Q4 2025: none, Q1 2026: none, Q2 2026: none, Q3 2026: 855,015
RTORentokil Initial Plc0.5%NEW (+$11.8M)596,811$11.8MQ3 2025: none, Q4 2025: none, Q1 2026: none, Q2 2026: none, Q3 2026: 596,811

Largest sells in Q3 2026

StockOf portfolioLatest activitySharesValueLast 5 quarters
Janus HendersonJanus Henderson Group Plc–SOLD OUT (−$1.3B)––Q3 2025: 31.87M, Q4 2025: 31.87M, Q1 2026: 31.87M, Q2 2026: 25.65M, Q3 2026: none
FergusonFerguson Plc New–SOLD OUT (−$258M)––Q3 2025: 1.09M, Q4 2025: 1.09M, Q1 2026: 1.09M, Q2 2026: 1.09M, Q3 2026: none
IVZInvesco Ltd.0.3%↓ 83% (−$40.6M)280,000$8.4MQ3 2025: 14.63M, Q4 2025: 2.97M, Q1 2026: 2.97M, Q2 2026: 1.63M, Q3 2026: 280,000

Sector allocation

Industrials is the largest sector at 56.3% of the portfolio in Q3 2026.

Q3 2026WeightChange
Industrials56.3%+20.7
Health care35.7%+16.1
Consumer discretionary7.5%+1.5
Finance0.3%-0.7
Consumer staples0.2%+0.1
Everything else0.0%-37.6
Everything else, Q3 2023: 26.1%Consumer staples, Q3 2023: 0.0%Finance, Q3 2023: 13.7%Consumer discretionary, Q3 2023: 50.9%Health care, Q3 2023: 1.4%Industrials, Q3 2023: 8.0%Q3 2023Everything else, Q4 2023: 25.3%Consumer staples, Q4 2023: 0.0%Finance, Q4 2023: 14.2%Consumer discretionary, Q4 2023: 50.4%Health care, Q4 2023: 1.5%Industrials, Q4 2023: 8.6%Everything else, Q1 2024: 19.9%Consumer staples, Q1 2024: 0.0%Finance, Q1 2024: 11.8%Consumer discretionary, Q1 2024: 56.7%Health care, Q1 2024: 1.5%Industrials, Q1 2024: 10.1%Everything else, Q2 2024: 35.4%Consumer staples, Q2 2024: 0.0%Finance, Q2 2024: 17.8%Consumer discretionary, Q2 2024: 21.4%Health care, Q2 2024: 9.5%Industrials, Q2 2024: 16.0%Q2 2024Everything else, Q3 2024: 37.7%Consumer staples, Q3 2024: 0.0%Finance, Q3 2024: 13.4%Consumer discretionary, Q3 2024: 16.6%Health care, Q3 2024: 12.8%Industrials, Q3 2024: 19.5%Everything else, Q4 2024: 40.5%Consumer staples, Q4 2024: 0.0%Finance, Q4 2024: 12.0%Consumer discretionary, Q4 2024: 15.8%Health care, Q4 2024: 14.4%Industrials, Q4 2024: 17.3%Everything else, Q1 2025: 35.2%Consumer staples, Q1 2025: 0.0%Finance, Q1 2025: 11.2%Consumer discretionary, Q1 2025: 14.8%Health care, Q1 2025: 17.2%Industrials, Q1 2025: 21.6%Q1 2025Everything else, Q2 2025: 38.9%Consumer staples, Q2 2025: 0.0%Finance, Q2 2025: 6.6%Consumer discretionary, Q2 2025: 10.2%Health care, Q2 2025: 16.9%Industrials, Q2 2025: 27.4%Everything else, Q3 2025: 40.5%Consumer staples, Q3 2025: 0.0%Finance, Q3 2025: 8.2%Consumer discretionary, Q3 2025: 6.8%Health care, Q3 2025: 15.0%Industrials, Q3 2025: 29.5%Everything else, Q4 2025: 44.1%Consumer staples, Q4 2025: 0.0%Finance, Q4 2025: 2.0%Consumer discretionary, Q4 2025: 6.4%Health care, Q4 2025: 16.4%Industrials, Q4 2025: 31.2%Q4 2025Everything else, Q1 2026: 49.0%Consumer staples, Q1 2026: 0.1%Finance, Q1 2026: 1.9%Consumer discretionary, Q1 2026: 5.5%Health care, Q1 2026: 13.9%Industrials, Q1 2026: 29.6%Everything else, Q2 2026: 37.6%Consumer staples, Q2 2026: 0.1%Finance, Q2 2026: 1.0%Consumer discretionary, Q2 2026: 6.0%Health care, Q2 2026: 19.7%Industrials, Q2 2026: 35.6%Everything else, Q3 2026: 0.0%Consumer staples, Q3 2026: 0.2%Finance, Q3 2026: 0.3%Consumer discretionary, Q3 2026: 7.5%Health care, Q3 2026: 35.7%Industrials, Q3 2026: 56.3%Q3 20260%50%100%

Sectors come from each company's SEC industry code (SIC), grouped into broad sectors. "Everything else" includes smaller sectors, funds and ETFs, and holdings we could not match to a company.

All holdings

StockClassOf portfolioValueSharesChange vs Q2 2026
Ge AerospaceCom New48.5%$1.3B4.03MNo change
Solventum CorporationCom Shs28.0%$726M8.24MNo change
Ge Healthcare Technologies Inc.Com7.8%$202M3.09MNo change
Wendys Co.Com7.5%$194M30.47MNo change
Ferguson Enterprises Inc.Common Stock New7.3%$190M855,015New
Rentokil Initial PlcSponsored Adr0.5%$11.8M596,811New
Invesco Ltd.Shs0.3%$8.4M280,000-83%
Magnum Ice Cream Co NvOrd Shs0.2%$4.3M241,042No change

Investors with the most similar portfolios

All investors

Overlap is the share of the two portfolios that sits in the same stocks at the same weight. 100% would be identical portfolios.

InvestorOverlapBiggest shared holdings

Value over time

The total value of the reported holdings, quarter by quarter

$2.6B at the end of Q3 2026, down 61% since Q3 2023.

Q3 2023Q2 2024Q1 2025Q4 2025Q3 2026$2.6B

The total value of the stocks listed in each 13F. It moves with prices as well as with buying and selling, and leaves out anything a 13F does not cover.

About Nelson Peltz and Trian Fund Management

Who runs Trian?

Trian Fund Management, also known as Trian Partners, was founded in November 2005 by Nelson Peltz, Peter May and Ed Garden. Peltz is chief executive and May is president. Garden left his role as chief investment officer in 2023. The firm is based in New York.

Trian calls itself a highly engaged shareowner. It takes large stakes in big companies and often seeks seats on the board. One of its largest contests was at Procter & Gamble in 2017. After a close and disputed vote, P&G added Peltz to its board, where he served until 2021.

What does Trian's 13F show?

The portfolio is very small. At the end of Q2 2026, Trian reported 9 lines covering 8 companies, worth about $4.2 billion in total. Two stakes made up more than two thirds of the value:

  • GE Aerospace, about 36%
  • Janus Henderson Group, about 32%
  • Solventum, about 15%

Ferguson, Wendy's, GE HealthCare, Invesco and Magnum Ice Cream made up the rest. The same 8 companies appeared in the Q1 2026 filing. When a portfolio is this concentrated, one new stake or one exit changes the picture a lot.

Where else does Trian report its stakes?

Trian files Schedule 13D when it owns more than 5% of a company and may seek to influence it. A 13D is due within days of crossing the line, much sooner than the 13F, and it must be updated when the stake changes in a material way. Trian has filed many 13D amendments over the years. Company proxy statements show when Trian partners sit on a board.

What is missing from Trian's 13F?
  • Foreign-listed shares do not appear.
  • Private holdings and derivatives other than listed options are not reported.
  • Timing. The 13F arrives up to 45 days after quarter end.

Other famous investors

All investors

Source: 13F-HR filing 0001345471-26-000051. A 13F lists long positions in US-listed stocks and some options at quarter end; it leaves out short positions, cash, bonds and most foreign stocks. Options rows are left out here. Data only, not investment advice. Methodology.